Focused on the development and manufacturing of biosimilar medicines, the company builds versions of high‑revenue biologic drugs whose patents are expiring. Its pipeline targets treatments for autoimmune diseases, cancer, and other chronic conditions, often commercialized through global partners suc...
No congressional trades have been disclosed for Alvotech (ALVO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.